Highbury Group

Highbury Group is an early-stage venture capital firm based in Seattle, Washington, founded in 2014 by Dr. Ling Wong. The firm is dedicated to partnering with entrepreneurs to develop transformative technologies across various sectors, including life sciences, healthcare, software, consumer products, and emerging platforms. Dr. Wong, who has a strong background in health and technology investments, aims to leverage scientific advancements to create companies that positively impact humanity. Her experience includes establishing substantial investment portfolios at the Gates Foundation and making significant contributions to notable investments and exits in the industry. Highbury Group seeks to disrupt the status quo by supporting innovative solutions that enhance human health and societal well-being.

Ling Wong

Founder and General Partner

8 past transactions

Devoted

Series E in 2023
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.

ScienceIO

Seed Round in 2021
ScienceIO is a biomedical language platform founded in 2019 by Gaurav Kaushik and Will Manidis in Massachusetts, United States. The company specializes in transforming unstructured biomedical data into usable and contextualized information. Its platform detects and extracts biomedical terms, clinical variables, and medical codes from complex medical texts, enabling the conversion of intricate information into actionable insights. By linking medical concepts, ScienceIO facilitates powerful queries, providing clients with easy access to relevant medical alternatives through the decoding of medical data.

Q Bio

Series B in 2020
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in fields such as applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Edify

Seed Round in 2019
Edify is a cloud-native platform that provides an integrated solution for contact center operations and unified communications. Its flagship product, Edify CX, offers an omnichannel experience that allows users to engage with customers across various channels from a single interface. The platform incorporates artificial intelligence and machine learning to enhance automated assistance, ensuring efficient problem resolution. In addition to Edify CX, the company offers Edify EX for unified communications, Edify Developer for communication platform as a service (CPaaS), and Edify Workflows for no-code automation solutions. Edify aims to strengthen connections between businesses and their customers while facilitating seamless communication across teams. The company also guarantees a 100% uptime service level agreement, reflecting its commitment to reliability in technology.

Cradle Genomics

Series A in 2019
Cradle Genomics, Inc. specializes in fetal genetic analysis and pregnancy health screening solutions, focusing on non-invasive prenatal testing (NIPT) to provide comprehensive insights at the earliest stages of pregnancy. Founded in 2018 and headquartered in San Diego, California, with research and development operations in Detroit, Michigan, the company has developed a platform that analyzes genetic material from fetal cells collected during a first trimester visit. This approach allows pregnant women to receive critical information about their health and the health of their developing fetus without any risk. Cradle Genomics aims to empower expectant parents with knowledge that can guide their decisions throughout the pregnancy journey.

Devoted

Series B in 2018
Devoted Health, established in 2017 and headquartered in Newton, Massachusetts, specializes in providing comprehensive healthcare solutions for Medicare beneficiaries in the United States. The company offers Medicare Advantage plans, along with personalized care through dedicated health guides, both in-person and virtually. Devoted Health aims to improve the health and well-being of older Americans by combining access to top local providers, virtual and in-home care through Devoted Medical, and advanced technology to deliver tailored healthcare experiences.

Spring Discovery

Seed Round in 2018
Spring Discovery, Inc. is a biotechnology company based in Palo Alto, California, focused on advancing the discovery of therapies aimed at aging and related diseases. By utilizing a machine learning-based platform, the company targets the biological processes of aging to identify potential treatments for various age-related conditions, including cardiovascular and neurodegenerative diseases. The innovative approach of leveraging machine learning enhances the efficiency of experimentation, facilitating the rapid development of new therapies designed to increase healthy lifespans.

Q Bio

Series A in 2018
Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in fields such as applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.